All In Biotech

Drug Trial Radar · NCT07513285

ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection

A Phase 2 Interventional, Open-Label, Single-Arm Trial of Oral Ibezapolstat (ACX-362E) for Treatment and Reduction of Recurrent Clostridioides Difficile Infection in Patients With Multiple Recurrent Infections (IBZ-PATHFINDER)

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Sep 25, 2026

Primary completion

Sep 29, 2027

Study completion Nov 24, 2027

Sponsor

Lead sponsor
Acurx Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Apr 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Single-arm trial to evaluate the safety and efficacy of ACX-362E \[ibezapolstat\] in patients with recurrent C. difficile infection (CDI).

Conditions

  • Clostridium Difficile Infection Recurrence

Interventions

  • IbezapolstatDrug

    Ibezapolstat 450 mg po Q12H x14 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluate the rate of CDI Clinical Cure (CC)Time frame: Day 16
  2. Evaluate the rate of Sustained Clinical Cure (SCC)Time frame: Day 42
  3. Evaluate the rate of CDI recurrence (rCDI)Time frame: Day 70

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • UC Davis Medical Center

    Sacramento, California · Not yet recruiting

  • Gastroenterolgy Center of Conneticut

    Hamden, Connecticut · Recruiting

  • Florida International Medical Research

    Coral Gables, Florida · Recruiting

  • L&A Morales Healthcare, Inc

    Hialeah, Florida · Recruiting

  • San Marcus Research Clinc, Inc

    Miami Lakes, Florida · Recruiting

  • Belis Delgado, MD PA

    Miami Springs, Florida · Recruiting

  • Infectious Disease Consultants of Georgia

    Athens, Georgia · Recruiting

  • Snake River Research PLLC

    Idaho Falls, Idaho · Recruiting

  • Endevour Health

    Skokie, Illinois · Recruiting

  • Newton-Wellesley Hospital

    Newton, Massachusetts · Recruiting

  • University of Massachusetts Memorial Healthcare

    Worcester, Massachusetts · Recruiting

  • Henry Ford Hospital

    Detroit, Michigan · Recruiting

  • University of Minnesota

    Minneapolis, Minnesota · Not yet recruiting

  • DiGiovanna Institute for Medical Education and Research

    Massapequa, New York · Recruiting

  • Gastroenterology Associates of the Piedmont, PA

    Winston-Salem, North Carolina · Recruiting

  • University of Cincinnati

    Cincinnati, Ohio · Not yet recruiting

  • Romano, Pontzer & Associated

    Pittsburgh, Pennsylvania · Recruiting

  • Southern Star Research Institute, LLC

    San Antonio, Texas · Recruiting

  • University of Utah

    Salt Lake City, Utah · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.